$CERT

Certara, Inc. presented at the Barclays 28th Annual Global Healthcare Conference, discussing its latest innovations and growth opportunities in the healthcare sector. The presentation highlighted strong partnerships and advancements in drug development technology, which could position the company favorably against its competitors. Analysts noted a positive outlook on Certara's financial performance due to increasing demand for their services in biopharma and regulatory submissions. The market reacted positively to the news, which could lead to increased investor confidence. Overall, Certara remains a key player in the healthcare analytics space, showing potential for future growth.